Related Experiment Video
Updated: Jan 10, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
Re-evaluating omega-3 (EPA/DHA) in cancer prevention and management
Alessio Molfino1,2, Maurizio Muscaritoli2, Federica Tambaro2
1Department of Interdisciplinary Studies on WellBeing, Health and Environmental Sustainability (BeSSA).
Purpose Of Review:
This review summarizes the most recent evidence on the role of omega-3 polyunsaturated fatty acids (PUFAs) in oncology, focusing on cancer prevention, cachexia and body composition, treatment-related toxicities, and therapeutic response.
Recent Findings:
Recent large-scale epidemiological and biomarker-based studies confirm a consistent, dose-dependent inverse association between eicosapentaenoic acid (EPA) and colorectal cancer risk, while evidence for docosahexaenoic acid (DHA) remains less consistent. Observational data reinforce the protective role of omega-3-rich dietary patterns, such as the Mediterranean and MIND diets, in reducing cancer risk. In clinical settings, omega-3 PUFA supplementation has shown modest but significant clinical benefits on body weight, inflammation, and quality of life in cancer cachexia, though effects on lean mass are variable. Promising data also support a reduction in severe oral mucositis during chemotherapy, whereas trials on chemotherapy-induced peripheral neuropathy and chemosensitization have produced inconclusive results, mainly due to heterogeneity in design and adherence.
Summary:
Omega-3 fatty acids exert measurable biological and clinical effects in oncology, however, their benefits appear context-dependent. Future studies should focus on standardized interventions, patient stratification based on molecular and inflammatory profiles, and integration within immunonutrition frameworks to enhance therapeutic precision and clinical outcomes.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

